In partnership with

On Thursday, CPI numbers came in hotter than they were predicted to be, showing us that inflation is not really going away.

More importantly, for us, the price of palladium is lining up to rocket up.

Take a look at the above chart and you can see how its 200-day Bollinger Bands are coming together, doing so while palladium has been trading in a stage one base, with long-term price resistance at $1100 an ounce.

This is the same situation gold was in back in February, silver was in March, and the Chinese stock market was in last month.

So, yes I’m watching palladium very closely now.

The $1100 level on it is like what $26 for silver was back in March.

Are you watching it?

I know of ZERO Bitcoin gurus who are even talking about it.

No “AI” was used to write this email or edit it.

In an internet where so much is phony and fake, as of today, 9,753 real people subscribe to this email newsletter.

Natural Is planning to list on the Nasdaq

Natural solutions are already better for the environment. Med-X is taking it a step further: their natural pesticides outperform various chemical alternatives. Better yet, they’re taking on private investors as they plan their Nasdaq listing (ticker: MXRX). And you now have a limited time to invest before it happens. Med-X has had 200% revenue growth in five years. And with the pesticide market expected to grow 3X by the end of the decade, now is the perfect time to join them.

Invest Before Their Nasdaq Plans

And…..

Last week I talked about ANET as a stock to watch for a breakout to new highs and yesterday it did it, while the Nasdaq had a down day.

Now ANET didn’t soar, even if it went up.

This was just a very short-term consolidation and consolidations lead to bigger moves when they take months to play out instead of days.

I didn’t actually buy the stock or trade it, but I do own a major palladium mining stock, as WSW Pro members know.

-Mike

^{Disclaimer: The opinions expressed in this newsletter are those of WallstreetWindow its editors and contributors, and may change without notice. The information in this newsletter may become outdated and we have no obligation to update it. The information in this newsletter is not intended to constitute individual investment advice and is not designed to meet your personal financial situation. It is provided for information purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor or a group of investors. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. We strongly advise you to discuss your investment options with a financial adviser prior to making any investments, including whether any investment is suitable for your specific needs. WallStreetWindow is owned by Timingwallstreet, Inc. and it is not a registered investment advisor and does not provide individual investment advice. This is a publication for the general public.}